Empowered Funds LLC Grows Stock Holdings in Humana Inc. $HUM

Empowered Funds LLC raised its stake in shares of Humana Inc. (NYSE:HUM) by 58.1% in the 2nd quarter, Holdings Channel reports. The fund owned 55,492 shares of the insurance provider’s stock after acquiring an additional 20,399 shares during the quarter. Empowered Funds LLC’s holdings in Humana were worth $13,567,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Revolve Wealth Partners LLC purchased a new stake in shares of Humana during the fourth quarter worth approximately $202,000. Private Advisor Group LLC acquired a new position in Humana in the 1st quarter valued at $443,000. Kestra Private Wealth Services LLC raised its position in Humana by 4.1% during the 1st quarter. Kestra Private Wealth Services LLC now owns 2,648 shares of the insurance provider’s stock worth $701,000 after buying an additional 105 shares during the last quarter. Teachers Retirement System of The State of Kentucky lifted its stake in shares of Humana by 4.0% in the 1st quarter. Teachers Retirement System of The State of Kentucky now owns 9,293 shares of the insurance provider’s stock worth $2,459,000 after acquiring an additional 361 shares during the period. Finally, Lindbrook Capital LLC lifted its stake in shares of Humana by 61.1% in the 1st quarter. Lindbrook Capital LLC now owns 1,020 shares of the insurance provider’s stock worth $270,000 after acquiring an additional 387 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

HUM has been the topic of a number of recent analyst reports. Barclays cut their price target on shares of Humana from $315.00 to $245.00 and set an “equal weight” rating for the company in a report on Friday, October 3rd. Sanford C. Bernstein increased their target price on Humana from $269.00 to $341.00 and gave the stock an “outperform” rating in a research note on Friday, September 5th. Robert W. Baird decreased their price target on Humana from $300.00 to $297.00 and set a “neutral” rating on the stock in a research note on Friday, July 25th. Truist Financial dropped their price objective on Humana from $300.00 to $285.00 and set a “hold” rating on the stock in a report on Monday, November 10th. Finally, Bank of America raised their target price on Humana from $280.00 to $300.00 and gave the company a “neutral” rating in a report on Friday, October 10th. Eight analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, Humana has a consensus rating of “Hold” and an average target price of $298.39.

Humana Stock Performance

NYSE HUM opened at $234.55 on Wednesday. Humana Inc. has a 1-year low of $206.87 and a 1-year high of $315.35. The company has a market capitalization of $28.21 billion, a P/E ratio of 18.00, a PEG ratio of 1.71 and a beta of 0.42. The business has a 50 day moving average price of $268.77 and a 200 day moving average price of $257.69. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. Humana had a return on equity of 13.67% and a net margin of 1.28%.The company had revenue of $32.65 billion for the quarter, compared to the consensus estimate of $31.99 billion. During the same period in the previous year, the business earned $4.16 earnings per share. Humana’s quarterly revenue was up 11.1% compared to the same quarter last year. Sell-side analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.5%. The ex-dividend date is Friday, December 26th. Humana’s dividend payout ratio (DPR) is 33.18%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.